X0609 4 2026-07-27 0001635088 Roivant Sciences Ltd. ROIV 0001801917 Venker Eric true C/O ROIVANT SCIENCES LTD. 7TH FLOOR, 50 BROADWAY LONDON X0 SW1H 0DB UNITED KINGDOM true President & Immunovant CEO true Common Shares 2026-07-27 4 M 0 200000 3.85 A 1813063 D Common Shares 2026-07-27 4 S 0 200000 34.95 D 1613063 D Stock Option (Right to Buy) 3.85 2026-07-27 4 M 0 200000 0 D 2032-04-19 Common Stock 200000 4044834 D The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.62 to $35.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. Reflects an award of stock options to purchase Common Shares that is fully vested. Exhibit 24 - Power of Attorney By: /s/ Sam Kaplan, as Attorney-in-Fact for Eric Venker 2026-07-29